About Cullinan Oncology
Cullinan Oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. Sourced from the Cullinan dry lab as well as external collaborators, Cullinan’s assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.
Co-Founder and CSO: Patrick Baeuerle, PhD
CEO: Owen Hughes
CSO: Leigh Zawel, PhD
Please click here for Cullinan Oncology's approach.
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.